API
Click for more information
0.00% $1.53 australian pharmaceutical industries limited

Ann: Revised Non-Binding Indicative Proposal from Wesfarmers, page-9

  1. aaa53
    247 Posts.
    lightbulb Created with Sketch. 60
    clock Created with Sketch.
    16/09/21
    12:35
    Post #: 56115083
    given API board supports the latest bid and only stopper is "due diligence".

    appears todays market price of 1.48 vs 1.55 has a very high spread for Due diligence.

    looks like an easy couple of % profit to buy at 1.48 ....am I missing something?
    API Price at posting: $1.48 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.